Tacstick 0.75 Capsule contains Tacrolimus 0.75 mg, a potent calcineurin inhibitor and immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This capsule works by inhibiting T-lymphocyte activation via calcineurin suppression, reducing immune-mediated damage to transplanted organs. It is ideal for patients requiring precise low-dose immunosuppression under specialist supervision.
Clinically, Tacstick 0.75 Capsule is used in renal, hepatic, and cardiac transplant protocols, often in combination with corticosteroids and other immunosuppressive agents, to maintain graft survival and minimize rejection episodes.
The capsule ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty pharmacies, and clinics managing post-transplant immunosuppressive therapy.
Common side effects include headache, tremors, nausea, diarrhea, insomnia, and mild infections. Rare but serious adverse effects include nephrotoxicity, hypertension, neurotoxicity, hyperglycemia, and severe infections.
Tacstick 0.75 Capsule is indicated for the prevention of organ transplant rejection in renal, hepatic, or cardiac transplant recipients. It is also used for the management of certain autoimmune disorders, under specialist supervision.
Use Tacstick 0.75 Capsule strictly under medical supervision. Regular monitoring of kidney function, blood pressure, drug levels, and signs of infection is essential. Inform your doctor of any history of kidney or liver disease, diabetes, or concurrent medications. Avoid live vaccines and seek immediate medical attention if you notice fever, unusual bleeding, or neurological symptoms.
Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children. Do not use beyond the expiry date.